Decentralized clinical trials - A more patient-centric approach

Published on: May 10, 2021

Decentralized clinical trials, where portions of a study are conducted outside a traditional trial site, offer new opportunities — and new hope — for patients struggling with inflammatory conditions.


Get Exclusive PDF Access

Return to Insights Center

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Blog

Including patients in DCT design

Sep 13, 2022

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Video

Part 2: Risk-based Quality Management Video (RBQM) Series

Nov 11, 2021

Podcast

Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training

Jun 28, 2024

Blog

Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression

Apr 23, 2024

Blog

Decentralized Trials: Considerations for Building a New Patient-Centric Model

May 13, 2021

Report

New Medicines, Novel Insights: Advancing rare disease drug development

May 22, 2023

Blog

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

Apr 25, 2022

Related Insights

Report

New Medicines, Novel Insights: Accelerating development of cell and gene therapies

May 22, 2023

Blog

A patient-centric approach to managing clinical trial complexity

Jul 13, 2021

Blog

Including patients in DCT design

Sep 13, 2022

Blog

Best practices and lessons learned in a challenging IBD study

Jul 19, 2023

Article

Australia: Infrastructure and Innovations for Clinical Trials

Aug 28, 2023

Report

New Medicines, Novel Insights: Achieving patient-guided drug development

Oct 30, 2023

Show more